SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Shubha Ambardekar, Tara Shochet, Hillary Bracken, Kurus Coyaji, Beverly Winikoff, Calibrated delivery drape versus indirect gravimetric technique for the measurement of blood loss after delivery: a randomized trial, BMC Pregnancy and Childbirth, 2014, 14, 1, 276

    CrossRef

  2. 2
    A. Garrigue, F. Pierre, Misoprostol : utilisation hors AMM dans la prise en charge de l’hémorragie du post-partum, Journal de Gynécologie Obstétrique et Biologie de la Reproduction, 2014, 43, 2, 179

    CrossRef

  3. You have free access to this content3
    WR Sheldon, J Blum, JP Vogel, JP Souza, AM Gülmezoglu, B Winikoff, Postpartum haemorrhage management, risks, and maternal outcomes: findings from the World Health Organization Multicountry Survey on Maternal and Newborn Health, BJOG: An International Journal of Obstetrics & Gynaecology, 2014, 121,
  4. 4
    A. Al-Sawaf, A. El-Mazny, A. Shohayeb, A randomised controlled trial of sublingual misoprostol and intramuscular oxytocin for prevention of postpartum haemorrhage, Journal of Obstetrics & Gynaecology, 2013, 33, 3, 277

    CrossRef

  5. 5
    Omar A Khan, Richard Derman, Nancy L Sloan, Advancing maternal survival in the global context: are our strategies working?, BMC Public Health, 2013, 13, 1, 689

    CrossRef

  6. You have free access to this content6
    J Hua, G Chen, F Xing, M Scott, Q Li, Effect of misoprostol versus oxytocin during caesarean section: a systematic review and meta-analysis, BJOG: An International Journal of Obstetrics & Gynaecology, 2013, 120, 5
  7. 7
    Jennifer Kerns, Jody Steinauer, Management of postabortion hemorrhage, Contraception, 2013, 87, 3, 331

    CrossRef

  8. 8
    Jeffrey Michael Smith, Rehana Gubin, Martine M Holston, Judith Fullerton, Ndola Prata, Misoprostol for postpartum hemorrhage prevention at home birth: an integrative review of global implementation experience to date, BMC Pregnancy and Childbirth, 2013, 13, 1, 44

    CrossRef

  9. 9
    Mervat S.-E.-A. Elsedeek, Impact of preoperative rectal misoprostol on blood loss during and after elective cesarean delivery, International Journal of Gynecology & Obstetrics, 2012, 118, 2, 149

    CrossRef

  10. 10
    Susan Fletcher, Chad A. Grotegut, Andra H. James, Lochia Patterns Among Normal Women: A Systematic Review, Journal of Women's Health, 2012, 21, 12, 1290

    CrossRef

  11. 11
    Wendy R Sheldon, Jennifer Blum, Jill Durocher, Beverly Winikoff, Misoprostol for the prevention and treatment of postpartum hemorrhage, Expert Opinion on Investigational Drugs, 2012, 21, 2, 235

    CrossRef

  12. 12
    MB Bellad, D Tara, MS Ganachari, MD Mallapur, SS Goudar, BS Kodkany, NL Sloan, R Derman, Prevention of postpartum haemorrhage with sublingual misoprostol or oxytocin: a double-blind randomised controlled trial, BJOG: An International Journal of Obstetrics & Gynaecology, 2012, 119, 8
  13. 13
    E. SØVIK, P. STOKKELAND, B. S. STORM, P. ÅSHEIM, O. BOLÅS, The use of aortic occlusion balloon catheter without fluoroscopy for life-threatening post-partum haemorrhage, Acta Anaesthesiologica Scandinavica, 2012, 56, 3
  14. 14
    Li Thies-Lagergren, Linda J Kvist, Kyllike Christensson, Ingegerd Hildingsson, No reduction in instrumental vaginal births and no increased risk for adverse perineal outcome in nulliparous women giving birth on a birth seat: results of a Swedish randomized controlled trial, BMC Pregnancy and Childbirth, 2011, 11, 1, 22

    CrossRef

  15. 15
    Hatem A Mousa, Jennifer Blum, Ghada Abou El Senoun, Haleema Shakur, Zarko Alfirevic, Treatment for primary postpartum haemorrhage, The Cochrane Library,